Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271870
Chembl Id: CHEMBL5271870
Max Phase: Preclinical
Molecular Formula: C34H48N6O6S
Molecular Weight: 668.86
Associated Items:
ID: ALA5271870
Chembl Id: CHEMBL5271870
Max Phase: Preclinical
Molecular Formula: C34H48N6O6S
Molecular Weight: 668.86
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CNC3CCOCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C34H48N6O6S/c1-6-32(4)15-23(33(5)19(2)7-11-34(20(3)28(32)44)12-8-22(41)27(33)34)46-25(43)17-47-30-26-29(37-18-36-26)39-31(40-30)38-24(42)16-35-21-9-13-45-14-10-21/h6,18-21,23,27-28,35,44H,1,7-17H2,2-5H3,(H2,36,37,38,39,40,42)/t19-,20+,23-,27?,28+,32-,33+,34+/m1/s1
Standard InChI Key: ROONDXRTOJNMCD-KQOHGKSUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 668.86 | Molecular Weight (Monoisotopic): 668.3356 | AlogP: 4.06 | #Rotatable Bonds: 9 |
Polar Surface Area: 168.42 | Molecular Species: BASE | HBA: 11 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.15 | CX Basic pKa: 11.50 | CX LogP: 1.80 | CX LogD: 1.62 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.13 | Np Likeness Score: 0.76 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):